Different Biomarkers of Response to Treatment with Selective Jak-1 Inhibitors in Rheumatoid Arthritis
Background: Rheumatoid arthritis (RA) is a systemic autoimmune disease that causes progressive joint damage. The Janus kinase (JAK) inhibitors (JAK-I) represent a new therapeutic option for RA patients, blocking the intracellular JAK-STAT pathway. Today, no studies have been conducted to determine w...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
IMR Press
2023-08-01
|
| Serier: | Frontiers in Bioscience-Landmark |
| Fag: | |
| Online adgang: | https://www.imrpress.com/journal/FBL/28/8/10.31083/j.fbl2808176 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
